Medical Biotechnology and Alzheimer’s disease

Alzheimer’s Disease the leading cause of Dementia worldwide is an unrecoverable progressive neurodegenerative Disease characterized by cognitive impairment and functional disability. presently, medical biotechnology has brought new expedients in the treatment of Alzheimer’s Disease. The brain has one in all the body's most extravagant fabrics of modes and is particularly helpless.

    Related Conference of Medical Biotechnology and Alzheimer’s disease

    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Medical Biotechnology and Alzheimer’s disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in